Tubidy MP3 & MP4

En popüler MP3 müziklerinizi ve MP4 videolarınızı ücretsiz indirin. Geniş bir multimedya içeriği seçkisini keşfedin ve sorunsuz indirmelerin tadını çıkarın.

Keynote: Modeling and Simulation to Guide Dose... | Husain Attarwala (Moderna) | JuliaCon 2022
Keynote: Modeling and Simulation to Guide Dose... | Husain Attarwala (Moderna) | JuliaCon 2022
|
Yükleniyor...
 Hızlı erişim için Tubidy'yi favorilerinize ekleyin.
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Keynote: Modeling and Simulation to Guide Dose... | Husain Attarwala (Moderna) | JuliaCon 2022

Keynote: Modeling and Simulation to Guide Dose... | Husain Attarwala (Moderna) | JuliaCon 2022

|
Keynote (Day 2). What makes a programming language successful? | Jeremy Howard | JuliaCon 2022

Keynote (Day 2). What makes a programming language successful? | Jeremy Howard | JuliaCon 2022

|
Keynote. API’s and Community: Building for Success | Erin LeDell | JuliaCon 2022

Keynote. API’s and Community: Building for Success | Erin LeDell | JuliaCon 2022

|
SparseVariables.jl: Efficient Sparse Modelling with JuMP | Lars Hellemo | JuliaCon 2022

SparseVariables.jl: Efficient Sparse Modelling with JuMP | Lars Hellemo | JuliaCon 2022

|
Julius Technologies | Sponsored Talk | JuliaCon 2022

Julius Technologies | Sponsored Talk | JuliaCon 2022

|
Julia Computing Sponsored Talk | JuliaCon 2022

Julia Computing Sponsored Talk | JuliaCon 2022

|
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

|
Discovery + Preclinical Track: High-Throughput Physiologically Based Pharmacokinetic Modeling and...

Discovery + Preclinical Track: High-Throughput Physiologically Based Pharmacokinetic Modeling and...

|
Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development

Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development

|
In Vitro-In Vivo Correlations and Human PK/Dose Predictions: What are the Hurdles?

In Vitro-In Vivo Correlations and Human PK/Dose Predictions: What are the Hurdles?

|
oneAPI.jl: Programming Intel GPUs (and More) in Julia | Tim Besard | JuliaCon 2022

oneAPI.jl: Programming Intel GPUs (and More) in Julia | Tim Besard | JuliaCon 2022

|
Blending Biophysics and Machine Learning to Predict the Antibody Response -Tal Einav, Ph.D.

Blending Biophysics and Machine Learning to Predict the Antibody Response -Tal Einav, Ph.D.

|
The Importance of PBPK Model Validation and Reproducibility in Obstetric Pharmacology

The Importance of PBPK Model Validation and Reproducibility in Obstetric Pharmacology

|
The State of Julia (In 2022) with Jeff Bezanson | JuliaCon 2022

The State of Julia (In 2022) with Jeff Bezanson | JuliaCon 2022

|
Lessons Learned from COVAX: Implications for Future Pandemic Preparedness and Response

Lessons Learned from COVAX: Implications for Future Pandemic Preparedness and Response

|
COVID-19, mRNA and the Future of Vaccines by Amesh Adalja

COVID-19, mRNA and the Future of Vaccines by Amesh Adalja

|
Use of PBPK Modeling in In Vitro to In Vivo Extrapolation (IVIVE)

Use of PBPK Modeling in In Vitro to In Vivo Extrapolation (IVIVE)

|
4. Nanovaccines - from Packaging to Targeting and Controlled Degradation

4. Nanovaccines - from Packaging to Targeting and Controlled Degradation

|

Favorilere Ekle